Group 1 - The core point of the article highlights the financing activities of Hong Kong New Drug (513780) on July 30, with a financing buy amount of 0.32 billion yuan, ranking 660th in the two markets [1] - Over the last three trading days from July 28 to July 30, Hong Kong New Drug received financing buys of 0.13 billion yuan, 0.39 billion yuan, and 0.32 billion yuan respectively [1] - On the same day, the company had no short selling activity, with both short selling and net selling at 0.00 shares [1]